Skip to main content
Premium Trial:

Request an Annual Quote

Pressure BioSciences Expects $623K Tax Refund under ARRA

NEW YORK (GenomeWeb News) – Pressure BioSciences today said that it expects to file for a refund of taxes paid for the 2004 calendar year, which would provide the company with $623,000 in the first quarter of 2009.

The South Easton, Mass.-based firm said that under the recently enacted American Recovery and Reinvestment Act, small businesses are eligible to claim the five-year carry back of 2008 net operating losses. Pressure Bio said that it expects to for the refund within the next 90 days.

The company noted that it recently completed a private placement that brought in net proceeds of around $1.8 million. With the extra funds from the tax refund, pressure Bio said that its total stockholders' equity as of Feb. 28, is more than $3.5 million.

"Because of the additional funds that will soon be available to us through the ARRA NOL provision, we have recently re-hired two former employees who were released last November as part of the company's announced restructuring plan, one of whom is full time and the other is part time," Pressure Bio President and CEO Richard Schumacher said in a statement. "These two employees fill vacant but extremely important positions; having them back will help ensure that we meet, or perhaps even beat, our June 30th PCT-enhanced [Protein Digestion System] product release date.''

In December, Pressure Bio undertook a restructuring program, which included cutting eight staffers and closing its R&D facility in Rockville, Md.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.